Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Barron

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Managed Care & Specialty Pharmacy|August 31, 2017
Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial FibrillationGboyega Adeboyeje, Gosia Sylwestrzak, John J Barron, et al.
Current Medical Research and Opinion|November 11, 2003
Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medicationsIbrahim S Al-Zakwani, John J Barron, Michael F Bullano, et al.
JAMA Oncology|April 17, 2020
Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast CancerRavi B Parikh, Ezra Fishman, Winnie Chi, et al.
JCO Oncology Practice|January 6, 2025
Treatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical DataDaniel M Geynisman, Nathan R Hill, Lisa C Rosenblatt, et al.
Pharmacoepidemiology and Drug Safety|February 5, 2025
The Healthcare Integrated Research Database (HIRD) as a Real-World Data Source for Pharmacoepidemiologic ResearchJohn J Barron, Vincent J Willey, Brett T Doherty, et al.
Pragmatic and Observational Research|September 13, 2017
A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims dataDavid M Kern, John J Barron, Bingcao Wu, et al.
Vascular Health and Risk Management|February 15, 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular diseaseThomas P Power, Xuehua Ke, Zhenxiang Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast CancerAbiy Agiro, Qinli Ma, Anupama Kurup Acheson, et al.
JCO Oncology Practice|July 13, 2022
Trends in Medically Integrated Dispensing Among Oncology PracticesGenevieve P Kanter, Ravi B Parikh, Michael J Fisch, et al.
American Heart Journal|March 10, 2010
Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research DatabaseJohn L Petersen, John J Barron, Bradley G Hammill, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Managed Care & Specialty Pharmacy|August 31, 2017
Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial FibrillationGboyega Adeboyeje, Gosia Sylwestrzak, John J Barron, et al.
Current Medical Research and Opinion|November 11, 2003
Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medicationsIbrahim S Al-Zakwani, John J Barron, Michael F Bullano, et al.
JAMA Oncology|April 17, 2020
Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast CancerRavi B Parikh, Ezra Fishman, Winnie Chi, et al.
JCO Oncology Practice|January 6, 2025
Treatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical DataDaniel M Geynisman, Nathan R Hill, Lisa C Rosenblatt, et al.
Pharmacoepidemiology and Drug Safety|February 5, 2025
The Healthcare Integrated Research Database (HIRD) as a Real-World Data Source for Pharmacoepidemiologic ResearchJohn J Barron, Vincent J Willey, Brett T Doherty, et al.
Pragmatic and Observational Research|September 13, 2017
A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims dataDavid M Kern, John J Barron, Bingcao Wu, et al.
Vascular Health and Risk Management|February 15, 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular diseaseThomas P Power, Xuehua Ke, Zhenxiang Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast CancerAbiy Agiro, Qinli Ma, Anupama Kurup Acheson, et al.
JCO Oncology Practice|July 13, 2022
Trends in Medically Integrated Dispensing Among Oncology PracticesGenevieve P Kanter, Ravi B Parikh, Michael J Fisch, et al.
American Heart Journal|March 10, 2010
Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research DatabaseJohn L Petersen, John J Barron, Bradley G Hammill, et al.
Pageof 2